Advertisement
Screener

Cingulate Inc. (CING) Cash Flow Breakdown

Cingulate Inc. Cash Flow Breakdown

Cash flow breakdown shows where Cingulate Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $17.25M went out.
  • Fiscal year ended 2025-12-31: from investing, $162.14K went out.
  • Fiscal year ended 2025-12-31: from financing, $16.15M came in.
  • Fiscal year ended 2025-12-31: change in cash, $1.26M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$17.25M-$162.14K$10.15M$6.00M*-$1.26M
2024-12-31-$18.45M-$211.80K$25.88M$4.95M*$12.16M
2023-12-31-$15.03M-$224.10K$6.97M$2.98M*-$5.30M
2022-12-31-$15.88M-$152.65K$4.90M*-$11.14M
2021-12-31-$10.43M-$814.74K$20.37M$6.17M*$15.30M
2020-12-31-$6.81M-$384.17K$7.97M*$779.20K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-06-30-$5.90M*-$67.08K*$9.14M*-$660.00K*
2026-03-31-$6.91M-$61.18K$21.91M$14.94M
2025-12-31-$3.60M*-$156.21K*$2.59M*$6.00M*
2025-09-30-$4.24M*$0.00*$1.46M*
2025-06-30-$4.80M*$4.18M*
2025-03-31-$4.61M$1.92M-$2.69M
2024-12-31-$4.08M*-$198.46K*$1.49M*$4.96M*
2024-09-30-$3.88M*$140.79K*$13.41M*
2024-06-30-$1.74M*-$72.63K*$1.09M*
2024-03-31-$8.75M-$81.51K$9.89M$1.06M
2023-12-31-$2.56M*-$186.96K*$819.54K*
2023-09-30-$4.29M*$0.00*$5.93M*
2023-06-30-$4.60M*-$1.00*$355.24K$2.86M*
2023-03-31-$3.58M-$37.13K-$3.62M
2022-12-31-$4.21M*-$143.02K*
2022-09-30-$3.40M*$3.25K*$5.00M*
2022-06-30-$4.41M*-$2.48K*
2022-03-31-$3.86M-$10.40K-$3.88M
2021-12-31-$4.62M*-$710.01K*$19.91M*
2021-09-30-$2.59M*-$15.77K*$3.47M*
2021-06-30-$1.55M*-$22.49K*$1.81M*
2021-03-31-$1.67M-$66.47K$1.35M*-$389.43K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
OS Therapies Inc (OSTX)United States$0.076B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
iBio, Inc. (IBIO)United States$0.077B-2.94